CircuLex Human RBP4 ELISA Kit

CircuLex Human RBP4 ELISA Kit.



The CycLex Research Product CircuLex Human RBP4 ELISA Kit is used for the quantitative measurement of Human Retinol Binding Protein 4 (RBP4) in serum, plasma and other biological media. It can be used for 96 Assays.

Target: RBP4
Product Type: ELISA Kit
Size: 96 Assays
Application: ELISA
Research Area / Disease: Metabolism
Species Reactivity: Human
Sensitivity: better than 1.08 ng/mL of sample.
Measurement Range: Dilution factors need to be taken into consideration in calculating the Human RBP4 concentration. Results exceeding diluted Human RBP4 level of 100 ng/ml should be repeated with diluted samples.
Regulatory Statement: For Research Use Only. Not for use in diagnostic procedures.


  • Microplate
  • 10X Wash Buffer
  • Dilution Buffer
  • Human NGAL Standard
  • HRP conjugated Detection Antibody
  • Substrate Reagent
  • Stop Solution


  1. Kimura Y et al. Identification of candidate diagnostic serum biomarkers for Kawasaki disease using proteomic analysis. Sci Rep. 7, 43732 (2017)


  1. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, et al. : Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. : Nature 436: 356–62, 2005
  2. Maeda K, Cao H, Kono K, Gorgun CZ, Furuhashi M, Uysal KT, et al. : Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell Metab. 1: 107–119, 2005
  3. Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM. : Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274: 1377–9, 1996
  4. Wang Y, Lam KS, Kraegen EW, Sweeney G, Zhang J, Tso AW, Chow WS, Wat NM, Xu JY, Hoo RL, Xu A. : Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin. Chem. 53: 34-41, 2007
  5. van Dam RM, Hu FB. : Lipocalins and insulin resistance: etiological role of retinol-binding protein 4 and lipocalin-2? Clin. Chem. 53: 5-7, 2007
  6. Graham, T. E.; Yang, Q.; Bluher, M.; Hammarstedt, A.; Ciaraldi, T. P.; Henry, R. R.; Wason, C. J.; Oberbach, A.; Jansson, P.-A.; Smith, U.; Kahn, B. B.: Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. New Eng. J. Med. 354: 2552-2563, 2006.
  7. Cho YM, Youn BS, Lee H, Lee N, Min SS, Kwak SH, Lee HK, Park KS.: Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care. 29: 2457-61, 2006
  8. Haider DG, Schindler K, Prager G, Bohdjalian A, Luger A, Wolzt M, Ludvik B. Serum retinol-binding protein-4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab. 2006 Dec 12
Code CY-8072
Product Type ELISA Kit
Size 96 Assays
Application ELISA

Related Content:

Pathway Posters

AMPK Pathway

Pathway Posters


Pathway Posters

Regulation of eIF4E